A randomized Double-blind, Placebo-Controlled Phase 2 Study to Evaluate the Testicular Safety of Filgotinib in Adult Males with Moderately to Severely Active Ulcerative Colitis. Protocol GS-US-418-4297, Gilead Sciences, Inc. Current Project

participant